Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs — Informed

Committee MeetingHouse

Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs

Held

Tuesday, April 1, 2025

Rayburn House Office Building 2123

Held by

House Energy and Commerce Subcommittee on Health

Watch / read on Congress.gov

Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs — Informed